Swart JF, de Roock S, Nievelstein RJ, et al. Safety and efficacy of intravenous administration of bone-marrow derived mesenchymal stromal cells in therapy refractory juvenile idiopathic arthritis patients, a phase ib/iia pilot-study. EULAR 2018. Abstract OP0203.
Besluit over basispakket benadeelt patiënt
jun 2018 | Arthritis psoriatica, Osteoporose, Overig, RA